2026. Dupilumab Improves Symptoms and Quality of Life in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: RELIEVE-AD-PED Study. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s737. DOI:https://doi.org/10.25251/0y59xj91.